2-Aminopurine inhibits leptin receptor signal transduction. 2006

Toru Hosoi, and Naomi Matsunami, and Tomoko Nagahama, and Yasunobu Okuma, and Koichiro Ozawa, and Tsuyoshi Takizawa, and Yasuyuki Nomura
Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan.

Leptin is an important circulating signal for the regulation of food intake and body weight. In the present study, we investigated the effect of 2-aminopurine (2-AP), an inhibitor of double-strand RNA-activated protein kinase (PKR), on leptin signal transduction. 2-AP dose-dependently inhibited the leptin-induced phosphorylation of signal transducer and activator of transcription 3 (STAT3), extracellular signal-regulated kinase (ERK), and c-Jun N-terminal kinase (JNK) in HEK293 cells stably transfected with the Ob-Rb leptin receptor. On the other hand, we observed only slight inhibition of leptin-induced STAT3 activation by purine treatment, indicating that the inhibitory effect will be dramatically enhanced in the presence of an amino group. 2-AP did not inhibit PMA-induced ERK activation, indicating that the effect may be leptin-signal specific. The inhibitory effect of 2-AP was not mediated by newly synthesized protein because the inhibitory effect of 2-AP on leptin-induced STAT3 activation was not abrogated in the presence of the protein synthesis inhibitor cycloheximide. Interestingly, leptin did not induce PKR activation, suggesting that the effect of 2-AP on the leptin signal may be independent of PKR. Finally, 2-AP inhibited leptin-induced phosphorylation of the Ob-Rb leptin receptor. These results provide evidence of a novel action of 2-AP, i.e., inhibition of the activation of leptin signal transduction at the level of the Ob-Rb leptin receptor.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011500 Protein Synthesis Inhibitors Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. Protein Synthesis Antagonist,Protein Synthesis Antagonists,Protein Synthesis Inhibitor,Antagonist, Protein Synthesis,Antagonists, Protein Synthesis,Inhibitor, Protein Synthesis,Inhibitors, Protein Synthesis,Synthesis Antagonist, Protein,Synthesis Inhibitor, Protein
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D003720 Densitometry The measurement of the density of a material by measuring the amount of light or radiation passing through (or absorbed by) the material. Densitometries
D004229 Dithiothreitol A reagent commonly used in biochemical studies as a protective agent to prevent the oxidation of SH (thiol) groups and for reducing disulphides to dithiols. Cleland Reagent,Cleland's Reagent,Sputolysin,Clelands Reagent,Reagent, Cleland,Reagent, Cleland's
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013755 Tetradecanoylphorbol Acetate A phorbol ester found in CROTON OIL with very effective tumor promoting activity. It stimulates the synthesis of both DNA and RNA. Phorbol Myristate Acetate,12-Myristoyl-13-acetylphorbol,12-O-Tetradecanoyl Phorbol 13-Acetate,Tetradecanoylphorbol Acetate, 4a alpha-Isomer,12 Myristoyl 13 acetylphorbol,12 O Tetradecanoyl Phorbol 13 Acetate,13-Acetate, 12-O-Tetradecanoyl Phorbol,Acetate, Phorbol Myristate,Acetate, Tetradecanoylphorbol,Myristate Acetate, Phorbol,Phorbol 13-Acetate, 12-O-Tetradecanoyl,Tetradecanoylphorbol Acetate, 4a alpha Isomer
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections

Related Publications

Toru Hosoi, and Naomi Matsunami, and Tomoko Nagahama, and Yasunobu Okuma, and Koichiro Ozawa, and Tsuyoshi Takizawa, and Yasuyuki Nomura
November 2000, Transplant immunology,
Toru Hosoi, and Naomi Matsunami, and Tomoko Nagahama, and Yasunobu Okuma, and Koichiro Ozawa, and Tsuyoshi Takizawa, and Yasuyuki Nomura
February 1997, Biochemical and biophysical research communications,
Toru Hosoi, and Naomi Matsunami, and Tomoko Nagahama, and Yasunobu Okuma, and Koichiro Ozawa, and Tsuyoshi Takizawa, and Yasuyuki Nomura
January 2013, The Journal of veterinary medical science,
Toru Hosoi, and Naomi Matsunami, and Tomoko Nagahama, and Yasunobu Okuma, and Koichiro Ozawa, and Tsuyoshi Takizawa, and Yasuyuki Nomura
August 1999, Proceedings of the National Academy of Sciences of the United States of America,
Toru Hosoi, and Naomi Matsunami, and Tomoko Nagahama, and Yasunobu Okuma, and Koichiro Ozawa, and Tsuyoshi Takizawa, and Yasuyuki Nomura
January 2004, Cell biology international,
Toru Hosoi, and Naomi Matsunami, and Tomoko Nagahama, and Yasunobu Okuma, and Koichiro Ozawa, and Tsuyoshi Takizawa, and Yasuyuki Nomura
June 1997, Diabetes,
Toru Hosoi, and Naomi Matsunami, and Tomoko Nagahama, and Yasunobu Okuma, and Koichiro Ozawa, and Tsuyoshi Takizawa, and Yasuyuki Nomura
May 1998, Biochemical and biophysical research communications,
Toru Hosoi, and Naomi Matsunami, and Tomoko Nagahama, and Yasunobu Okuma, and Koichiro Ozawa, and Tsuyoshi Takizawa, and Yasuyuki Nomura
October 1998, Toxicology in vitro : an international journal published in association with BIBRA,
Toru Hosoi, and Naomi Matsunami, and Tomoko Nagahama, and Yasunobu Okuma, and Koichiro Ozawa, and Tsuyoshi Takizawa, and Yasuyuki Nomura
March 2005, European journal of endocrinology,
Toru Hosoi, and Naomi Matsunami, and Tomoko Nagahama, and Yasunobu Okuma, and Koichiro Ozawa, and Tsuyoshi Takizawa, and Yasuyuki Nomura
May 1998, The Journal of biological chemistry,
Copied contents to your clipboard!